171 related articles for article (PubMed ID: 16079929)
1. Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.
Kiortsis DN; Tsouli S; Lourida ES; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2005; 56(4):451-8. PubMed ID: 16079929
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals.
Campo S; Sardo MA; Bitto A; Bonaiuto A; Trimarchi G; Bonaiuto M; Castaldo M; Saitta C; Cristadoro S; Saitta A
Clin Chem; 2004 Nov; 50(11):2077-82. PubMed ID: 15364890
[TBL] [Abstract][Full Text] [Related]
3. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
4. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
[TBL] [Abstract][Full Text] [Related]
5. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
6. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
Tsimihodimos V; Kakafika A; Tambaki AP; Bairaktari E; Chapman MJ; Elisaf M; Tselepis AD
J Lipid Res; 2003 May; 44(5):927-34. PubMed ID: 12611907
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
[TBL] [Abstract][Full Text] [Related]
10. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
[TBL] [Abstract][Full Text] [Related]
11. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
14. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
Kujiraoka T; Hattori H; Ito M; Nanjee MN; Ishihara M; Nagano M; Iwasaki T; Cooke CJ; Olszewski WL; Stepanova IP; Egashira T; Miller NE
Atherosclerosis; 2004 Sep; 176(1):57-62. PubMed ID: 15306175
[TBL] [Abstract][Full Text] [Related]
16. Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins.
Balafa OC; Karabina SA; Pappas CA; Elisaf M; Tselepis AD; Siamopoulos KC
Nephron Physiol; 2004; 97(3):p45-52. PubMed ID: 15292677
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
Phumala Morales N; Cherlermchoung C; Fucharoen S; Chantharaksri U
Clin Chem Lab Med; 2007; 45(7):884-9. PubMed ID: 17617032
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Bayrak T; Dursun P; Bayrak A; Gültekin M; Kolusarı A; Cakır E; Ozyurt M; Zeyneloğlu HB
Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
[TBL] [Abstract][Full Text] [Related]
19. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
20. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
